Renee Risingsong

2.9k citations

30 papers · 2.5k indexed · h-index 26

Impact in

Toxicology top 1%
- Bioactive Compounds and Antitumor Agents
Molecular Biology top 5%
- Genomics, phytochemicals, and oxidative stress
- Natural product bioactivities and synthesis
- Glutathione Transferases and Polymorphisms
- Peroxisome Proliferator-Activated Receptors
- Retinoids in leukemia and cellular processes

Papers in ⓘ

Molecular Biology 24
- Genomics, phytochemicals, and oxidative stress 13
- Natural product bioactivities and synthesis 7
- Glutathione Transferases and Polymorphisms 3
Oncology 10
- Cytokine Signaling Pathways and Interactions 6

Co-authors: Michael B. Sporn (30 shared papers)Charlotte R. Williams (27 shared papers)Karen T. Liby (24 shared papers)Darlene B. Royce (22 shared papers)Nanjoo Suh (12 shared papers)Tadashi Honda (14 shared papers)Gordon W. Gribble (14 shared papers)Albena T. Dinkova‐Kostova (3 shared papers)
Journals: Cancer Prevention Research (7 papers)Clinical Cancer Research (4 papers)Cancer Research (4 papers)Molecular Cancer Therapeutics (2 papers)Carcinogenesis (2 papers)
Partner nations: United States United Kingdom Netherlands

In The Last Decade

Renee Risingsong

30 papers receiving 2.5k citations

Peers

Countries citing papers authored by Renee Risingsong

Since Specialization

Citations

This map shows the geographic impact of Renee Risingsong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renee Risingsong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renee Risingsong more than expected).

Fields of papers citing papers by Renee Risingsong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renee Risingsong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renee Risingsong. The network helps show where Renee Risingsong may publish in the future.

Co-authors

The 25 scholars most cited alongside Renee Risingsong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Renee Risingsong Line = papers co-authored together Renee Risingsong links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Extremely potent triterpenoid inducers of the phase 2 response: Correlations of protection against oxidant and inflammatory stress Proceedings of the National Academy of Sciences ·Albena T. Dinkova‐Kostova, Karen T. Liby, Katherine K. Stephenson, W. David Holtzclaw, Xiangqun Gao, Nanjoo Suh, Charlotte R. Williams, Renee Risingsong, Tadashi Honda, Gordon W. Gribble, Michael B. Sporn, Paul Talalay	2005	493
2	The Synthetic Triterpenoids, CDDO and CDDO-Imidazolide, Are Potent Inducers of Heme Oxygenase-1 and Nrf2/ARE Signaling Cancer Research ·Karen T. Liby, Thomas Hock, Mark M. Yore, Nanjoo Suh, Andrew E. Place, Renee Risingsong, Charlotte R. Williams, Darlene B. Royce, Tadashi Honda, Yukiko Honda, Gordon W. Gribble, Nathalie Hill‐Kapturczak, Anupam Agarwal, Michael B. Sporn	2005	239
3	A new ligand for the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), GW7845, inhibits rat mammary carcinogenesis. PubMed ·Nanjoo Suh, Yongping Wang, Charlotte R. Williams, Renee Risingsong, Tona M. Gilmer, Timothy M. Willson, Michael B. Sporn	1999	201
4	Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis Free Radical Biology and Medicine ·Arie Neymotin, Noel Y. Calingasan, Elizabeth Wille, Nima Naseri, Susanne Petri, Maria Damiano, Karen T. Liby, Renee Risingsong, Michael B. Sporn, M. Flint Beal, Mahmoud Kiaei	2011	171
5	Neuroprotective Effects of the Triterpenoid, CDDO Methyl Amide, a Potent Inducer of Nrf2-Mediated Transcription PLoS ONE ·Lichuan Yang, Noel Y. Calingasan, Bobby Thomas, Rajnish Kumar Chaturvedi, Mahmoud Kiaei, Elizabeth Wille, Karen T. Liby, Charlotte R. Williams, Darlene B. Royce, Renee Risingsong, Erik S. Musiek, Jason D. Morrow, Michael B. Sporn, M. Flint Beal	2009	144
6	The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivo. PubMed ·Andrew E. Place, Nanjoo Suh, Charlotte R. Williams, Renee Risingsong, Tadashi Honda, Yukiko Honda, Gordon W. Gribble, Lisa M. Leesnitzer, Julie B. Stimmel, Timothy M. Willson, Evan D. Rosen, Michael B. Sporn	2003	124
7	The Synthetic Triterpenoids CDDO-Methyl Ester and CDDO-Ethyl Amide Prevent Lung Cancer Induced by Vinyl Carbamate in A/J Mice Cancer Research ·Karen T. Liby, Darlene B. Royce, Charlotte R. Williams, Renee Risingsong, Mark M. Yore, Tadashi Honda, Gordon W. Gribble, Ethan Dmitrovsky, Thomas A. Sporn, Michael B. Sporn	2007	124
8	The Synthetic Triterpenoid CDDO-Imidazolide Suppresses STAT Phosphorylation and Induces Apoptosis in Myeloma and Lung Cancer Cells Clinical Cancer Research ·Karen T. Liby, Nga Voong, Charlotte R. Williams, Renee Risingsong, Darlene B. Royce, Tadashi Honda, Gordon W. Gribble, Michael B. Sporn, John J. Letterio	2006	98
9	Synthetic Triterpenoids Prolong Survival in a Transgenic Mouse Model of Pancreatic Cancer Cancer Prevention Research ·Karen T. Liby, Darlene B. Royce, Renee Risingsong, Charlotte R. Williams, Anirban Maitra, Ralph H. Hruban, Michael B. Sporn	2010	78
10	Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling. PubMed ·Nanjoo Suh, Anita B. Roberts, Stephanie Birkey Reffey, Kohei Miyazono, Susumu Itoh, Peter ten Dijke, Elke H. Heiß, Andrew E. Place, Renee Risingsong, Charlotte R. Williams, Tadashi Honda, Gordon W. Gribble, Michael B. Sporn	2003	76
11	Prevention and Treatment of Experimental Estrogen Receptor–Negative Mammary Carcinogenesis by the Synthetic Triterpenoid CDDO-Methyl Ester and the Rexinoid LG100268 Clinical Cancer Research ·Karen T. Liby, Renee Risingsong, Darlene B. Royce, Charlotte R. Williams, Mark M. Yore, Tadashi Honda, Gordon W. Gribble, William W. Lamph, Nicola Vannini, Ilaria Sogno, Adriana Albini, Michael B. Sporn	2008	66
12	Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis Carcinogenesis ·Ciric To, Carol S. Ringelberg, Darlene B. Royce, Charlotte R. Williams, Renee Risingsong, Michael B. Sporn, Karen T. Liby	2015	60
13	The PARP Inhibitors, Veliparib and Olaparib, Are Effective Chemopreventive Agents for Delaying Mammary Tumor Development in BRCA1-deficient Mice Cancer Prevention Research ·Ciric To, Eun‐Hee Kim, Darlene B. Royce, Charlotte R. Williams, Ryan M. Collins, Renee Risingsong, Michael B. Sporn, Karen T. Liby	2014	60
14	Prevention and treatment of experimental breast cancer with the combination of a new selective estrogen receptor modulator, arzoxifene, and a new rexinoid, LG 100268. PubMed ·Nanjoo Suh, William W. Lamph, Andrew L. Glasebrook, Timothy A. Grese, Alan D. Palkowitz, Charlotte R. Williams, Renee Risingsong, Manuela Farris, Richard A. Heyman, Michael B. Sporn	2002	55
15	The Selective Estrogen Receptor Modulator Arzoxifene and the Rexinoid LG100268 Cooperate to Promote Transforming Growth Factor β-Dependent Apoptosis in Breast Cancer Cancer Research ·Mara H. Rendi, Nanjoo Suh, William W. Lamph, Stan Krajewski, John C. Reed, Richard A. Heyman, Andrew Berchuck, Karen T. Liby, Renee Risingsong, Darlene B. Royce, Charlotte R. Williams, Michael B. Sporn	2004	54
16	CDDO-Methyl Ester Delays Breast Cancer Development in Brca1-Mutated Mice Cancer Prevention Research ·Eun‐Hee Kim, Chu‐Xia Deng, Michael B. Sporn, Darlene B. Royce, Renee Risingsong, Charlotte R. Williams, Karen T. Liby	2011	52
17	The Combination of the Rexinoid, LG100268, and a Selective Estrogen Receptor Modulator, Either Arzoxifene or Acolbifene, Synergizes in the Prevention and Treatment of Mammary Tumors in an Estrogen Receptor–Negative Model of Breast Cancer Clinical Cancer Research ·Karen T. Liby, Mara H. Rendi, Nanjoo Suh, Darlene B. Royce, Renee Risingsong, Charlotte R. Williams, William W. Lamph, Fernand Labrie, Stan Krajewski, Xiaochun Xu, Heetae Kim, Powel H. Brown, Michael B. Sporn	2006	51
18	Triterpenoids CDDO-Methyl Ester or CDDO-Ethyl Amide and Rexinoids LG100268 or NRX194204 for Prevention and Treatment of Lung Cancer in Mice Cancer Prevention Research ·Karen T. Liby, Renee Risingsong, Darlene B. Royce, Charlotte R. Williams, Tian Ma, Mark M. Yore, Michael B. Sporn	2009	50
19	Novel semisynthetic analogues of betulinic acid with diverse cytoprotective, antiproliferative, and proapoptotic activities Molecular Cancer Therapeutics ·Karen T. Liby, Tadashi Honda, Charlotte R. Williams, Renee Risingsong, Darlene B. Royce, Nanjoo Suh, Albena T. Dinkova‐Kostova, Katherine K. Stephenson, Paul Talalay, Chitra Sundararajan, Gordon W. Gribble, Michael B. Sporn	2007	50
20	A Novel Acetylenic Tricyclic bis-(Cyano Enone) Potently Induces Phase 2 Cytoprotective Pathways and Blocks Liver Carcinogenesis Induced by Aflatoxin Cancer Research ·Karen T. Liby, Mark M. Yore, Bill D. Roebuck, Karen J. Baumgartner, Tadashi Honda, Chitra Sundararajan, Hidenori Yoshizawa, Gordon W. Gribble, Charlotte R. Williams, Renee Risingsong, Darlene B. Royce, Albena T. Dinkova‐Kostova, Katherine K. Stephenson, Patricia A. Egner, Melinda S. Yates, John D. Groopman, Thomas W. Kensler, Michael B. Sporn	2008	42

About Renee Risingsong

Renee Risingsong is a scholar working on Molecular Biology, Oncology, Genetics, Toxicology and Cancer Research, having authored 30 papers that have together received 2.5k indexed citations. Recurring topics across this work include Genomics, phytochemicals, and oxidative stress (13 papers), Natural product bioactivities and synthesis (7 papers), Estrogen and related hormone effects (7 papers), Cytokine Signaling Pathways and Interactions (6 papers), Bioactive Compounds and Antitumor Agents (6 papers), Glutathione Transferases and Polymorphisms (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Synthesis and biological activity (2 papers). The work is most often cited by research in Toxicology (196 citations), Molecular Biology (2.0k citations), Cancer Research (354 citations), Biochemistry (122 citations) and Biological Psychiatry (49 citations). Renee Risingsong has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Michael B. Sporn, Charlotte R. Williams, Karen T. Liby, Darlene B. Royce, Nanjoo Suh, Tadashi Honda, Gordon W. Gribble, Albena T. Dinkova‐Kostova, Katherine K. Stephenson and Mark M. Yore. Their work appears in journals such as Cancer Prevention Research, Clinical Cancer Research, Cancer Research, Molecular Cancer Therapeutics and Carcinogenesis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact